Owlet Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St

March 18, 2023

Owlet (NYSE:OWLT) Full Year 2022 Results

Key Financial Results

Revenue: US$69.2m (down 8.8% from FY 2021).
Net loss: US$79.3m (loss widened by 11% from FY 2021).
US$0.71 loss per share.

earnings-and-revenue-growth — NYSE:OWLT Earnings and Revenue Growth March 18th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Owlet EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 2.1%.

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 14% from a week ago.

Risk Analysis

Before you take the next step you should know about the 4 warning signs for Owlet (2 are concerning!) that we have uncovered.

If you're looking to trade Owlet, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.